FBInvestor
Stocks / Pasithea Therapeutics Corp
Institutional Ownership

Pasithea Therapeutics Corp

CUSIP 70261F202COM NEWKTTAQ1 2026

13D / 13G Filings
17
Schedule 13D/13G on record
Beneficial Filers
12
Distinct reporting persons
Largest Stake
10.0%
Max % of class reported
Institutional Holders
19
13F filers (latest quarter)

Beneficial Owners — Schedule 13D / 13G

17 filings · latest Feb 27, 2026

Export CSV — Pro
#FiledReporting PersonForm% of ClassSharesFiling
1Feb 27, 2026Coastlands Capital LP13G10.0%SEC
2Feb 17, 2026Squadron Master Fund LP13G/A9.9%2.33MSEC
3Feb 17, 2026Cvi Investments, Inc.13G/A3.8%900.0KSEC
4Feb 17, 2026Ameriprise Financial, Inc.13G8.4%1.93MSEC
5Feb 12, 2026Adage Capital Management, L.P.13G10.0%2.33MSEC
6Dec 8, 2025Janus Henderson Group PLC13G10.0%10.23MSEC
7Dec 5, 2025Squadron Master Fund LP13G9.9%2.25MSEC
8Dec 5, 2025Vivo Opportunity Fund Holdings, L.P.13G10.0%17.56MSEC
9Aug 14, 2025Cvi Investments, Inc.13G/A9.9%826.1KSEC
10May 15, 2025Armistice Capital, LLC13G/A5.0%142.1KSEC

7 more beneficial-ownership filings on Premium

See the full Schedule 13D/13G history for Pasithea Therapeutics Corp.

Unlock full history

Top Institutional Holders (13F)

Largest reported positions · latest quarter

View all →